María Isabel González

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

Behavioral effects of α-MSH and MCH after central administration in the female rat

María Isabel González, S. M. Vaziri, C. A. Wilson · Peptides · 1996 · 195 citations

Central Administration, Endocrine Mechanism, Behavioral Neuroscience +14

Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients

V. Calvo-Río, Inmaculada Calvo, María Isabel González et al. · Arthritis & Rheumatology · 2016 · 150 citations

Identification of MEK1 as a novel target for the treatment of neuropathic pain

Antonio Ciruela, A. K. Dixon, S. Bramwell et al. · British Journal of Pharmacology · 2003 · 110 citations · Full text

Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis)

Marek Böhm, María Isabel González, Seza Özen et al. · Pediatric Rheumatology · 2014 · 107 citations · Full text